TIAA CREF Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.52M	Sell	12,173 -682	-5%	-$84.8K	﹤0.01%	2130
2018 Q4	$1.45M	Sell	12,855 -348	-3%	-$53.9K	﹤0.01%	2134
2018 Q3	$2.83M	Buy	13,203 +434	+3%	+$109K	﹤0.01%	1945
2018 Q2	$3.57M	Buy	12,769 +4,727	+59%	+$830K	﹤0.01%	1840
2018 Q1	$939K	Sell	8,042 -16,147	-67%	-$1.99M	﹤0.01%	2473
2017 Q4	$2.22M	Buy	24,189 +15,885	+191%	+$907K	﹤0.01%	2079
2017 Q3	$374K	Buy	8,304 +950	+13%	+$17.8K	﹤0.01%	2944
2017 Q2	$120K	Buy	+7,354	New	+$115K	﹤0.01%	3103
2015 Q4	–	Sell	-8,824	Closed	-$537K	–	3145
2015 Q3	$537K	Buy	8,824 +1,394	+19%	+$101K	﹤0.01%	2865
2015 Q2	$580K	Buy	7,430 +915	+14%	+$76.8K	﹤0.01%	2920
2015 Q1	$442K	Hold	6,515	–	–	﹤0.01%	2956
2014 Q4	$604K	Buy	6,515 +158	+2%	+$16.3K	﹤0.01%	2904
2014 Q3	$670K	Sell	6,357 -16	-0.3%	-$2.23K	﹤0.01%	2846
2014 Q2	$912K	Buy	6,373 +395	+7%	+$57.7K	﹤0.01%	2768
2014 Q1	$902K	Sell	5,978 -187	-3%	-$36.8K	﹤0.01%	2697
2013 Q4	$1.13M	Buy	6,165 +1,817	+42%	+$333K	﹤0.01%	2594
2013 Q3	$960K	Sell	4,348 -142	-3%	-$30.2K	﹤0.01%	2631
2013 Q2	$784K	Buy	+4,490	New	+$1.17M	﹤0.01%	2734